Opinion: Amid the Covid-19 pandemic, it is time for biomedical research investments to pay off
The Covid-19 pandemic is the monumental public health challenge the medical community has been fearing the past few decades. The price of this disease should convince Americans of the wisdom of our investment in biomedical research. If we seize the opportunity and capitalize on it, that investment will pay dividends.
As policymakers invest more than $2 trillion to stave off the economic impacts of the pandemic in the United States, the health sector is frantically working to treat the ill, discover effective treatments for the virus, and develop a vaccine that will be the difference between life and death for people around the world.
